Primary leiomyosarcoma of the breast: report of a case.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 12181723)

Published in Surg Today on January 01, 2002

Authors

Osamu Shinto1, Masakazu Yashiro, Nobuya Yamada, Tasuku Matsuoka, Masaichi Ohira, Tetsuro Ishikawa, Hiroji Nishino, Kosei Hirakawa

Author Affiliations

1: Department of Surgical Oncology (First Department of Surgery), Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Japan.

Articles by these authors

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med (2012) 5.44

FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival. Cancer Res (2008) 2.46

Improvement of cancer-targeting therapy, using nanocarriers for intractable solid tumors by inhibition of TGF-beta signaling. Proc Natl Acad Sci U S A (2007) 2.30

Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions. Digestion (2004) 2.19

Meta-analysis of the results of randomized controlled trials that compared laparoscopic and open surgery for acute appendicitis. J Gastrointest Surg (2012) 1.84

Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens. J Transl Med (2012) 1.47

Phase II study of oral S-1 for treatment of metastatic colorectal carcinoma. Cancer (2004) 1.44

Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: analysis for a cut-off point as the predictor for endocrine therapy. Breast Cancer (2004) 1.41

Prognostic value of microsatellite instability in resectable pancreatic cancer. Clin Cancer Res (2002) 1.39

Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism. Eur J Endocrinol (2006) 1.36

Primary hyperparathyroidism with multiple osteosclerotic lesions of the calvarium. J Bone Miner Res (2003) 1.35

An opposing view on WWOX protein function as a tumor suppressor. Cancer Res (2003) 1.27

Role of the stemness factors sox2, oct3/4, and nanog in gastric carcinoma. J Surg Res (2010) 1.27

Keratinocyte growth factor produced by gastric fibroblasts specifically stimulates proliferation of cancer cells from scirrhous gastric carcinoma. Cancer Res (2003) 1.22

Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis. Cancer Res (2007) 1.21

A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and open colectomy for colon cancer. J Cancer (2012) 1.18

Laparoscopic adrenalectomy on a patient with primary aldosteronism during pregnancy. Endocr J (2006) 1.15

A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer. Gastroenterology (2006) 1.15

Gastric metastasis from renal cell carcinoma with gastrointestinal bleeding: a case report and review of the literature. Int Surg (2014) 1.14

A meta-analysis of randomized controlled trials that compared laparoscopy-assisted and open distal gastrectomy for early gastric cancer. J Gastrointest Surg (2010) 1.13

Histone deacetylase inhibitor, trichostatin A, increases the chemosensitivity of anticancer drugs in gastric cancer cell lines. Oncol Rep (2006) 1.12

Antitumor effect of trastuzumab for pancreatic cancer with high HER-2 expression and enhancement of effect by combined therapy with gemcitabine. Clin Cancer Res (2006) 1.12

TIE2 gain-of-function mutation in a patient with pancreatic lymphangioma associated with blue rubber-bleb nevus syndrome: report of a case. Surg Today (2006) 1.12

A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer. Anticancer Res (2013) 1.11

Lymphangioma of the lesser omentum associated with abdominal esophageal carcinoma: report of a case. Surg Today (2002) 1.09

Vitamin D receptor expression is associated with colon cancer in ulcerative colitis. Oncol Rep (2009) 1.08

Decreased expression of the adhesion molecule desmoglein-2 is associated with diffuse-type gastric carcinoma. Eur J Cancer (2006) 1.08

CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer. PLoS One (2012) 1.08

Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts. Clin Cancer Res (2010) 1.08

HER2 overexpression correlates with survival after curative resection of pancreatic cancer. Cancer Sci (2009) 1.08

A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for rectal cancer. J Gastrointest Surg (2011) 1.07

Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling. J Natl Cancer Inst (2009) 1.07

Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma. Cancer Sci (2009) 1.06

Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer. Clin Cancer Res (2005) 1.06

Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron (2010) 1.03

Meta-analysis of laparoscopy-assisted and open distal gastrectomy for gastric cancer. J Surg Res (2010) 1.03

Is a lymph node detected by the dye-guided method a true sentinel node in gastric cancer? Clin Cancer Res (2004) 1.03

Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity. Oncol Rep (2010) 1.03

Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma. Cancer Sci (2009) 1.03

Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors. Anticancer Res (2013) 1.02

THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling. Mod Pathol (2011) 1.02

Adrenal schwannoma treated with laparoscopic surgery. JSLS (2009) 1.02

Decrease in carotid intima-media thickness in hypothyroid patients after normalization of thyroid function. Clin Endocrinol (Oxf) (2003) 1.02

DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells. Cancer Sci (2008) 1.01

Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line. J Exp Clin Cancer Res (2010) 1.01

Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67. Breast Cancer Res (2011) 1.01

Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma. Oncol Rep (2009) 1.00

Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer. J Exp Clin Cancer Res (2009) 1.00

Somatic mutations of epidermal growth factor receptor in colorectal carcinoma. Clin Cancer Res (2005) 1.00

Alternative pharmacokinetics of S-1 components, 5-fluorouracil, dihydrofluorouracil and alpha-fluoro-beta-alanine after oral administration of S-1 following total gastrectomy. Cancer Sci (2007) 1.00

Carcinoid tumor of the kidney presenting as a large abdominal mass: report of a case. Surg Today (2004) 0.99

Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β. J Pathol (2012) 0.99

c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-beta signaling in diffuse-type gastric carcinoma. Cancer Sci (2009) 0.99